etc.). These side effects can mask an accurate neurological assessment. Moreover, inadequate postoperative pain control may increase the incidence of postoperative complications. For example, postoperative pain that results in an increase in arterial blood pressure may also result in an intracranial hemorrhage. Therefore, it is important to consider alternative analgesic options, especially given the fact that the conservative management of post-craniotomy pain with opioids is often inadequate.
Intraoperative dexmedetomidine infusion has previously been shown to decrease postoperative opioid requirements in pediatric and adult surgeries. Song and colleagues conducted a randomized trial to evaluate the opioid-sparing effect of an intraoperative dexmedetomidine infusion after craniotomy. In addition to propofol and remifentanyl infusion, the treatment group received dexmedetomidine infusion at 0.2 to 0.5 mcg/kg/h beginning 10 minutes prior to induction, while the placebo group received a normal saline infusion. Infusion was stopped at the end of the surgery.
The present study demonstrated an opioid sparing effect of the intraoperatve infusion of dexmedetomidine as evidenced by (1) a reduced verbal numerical pain rating scale, (2) a prolonged time before an analgesic request, (3) a reduced opioid requirement to control postoperative pain, and (4) fewer opioid related side effects. Dexmedetomidine is a distinctive sedative because it offers a cooperative sedation (i.e. patient can respond to simple command while sedated) and it does not cause respiratory depression, although it may cause hypotension and bradycardia. The subjects of the study did not exhibit any perioperative bradycardia; presumably, due to the relatively low dose of continuous infusion without a bolus dose. In conclusion, the study confirms that dexmedetomidine may be added to the anesthetic regiment to reduce postoperative pain and opioid requirements. It should be noted that this therapy should be exercised with caution, especially in patients with known cardiac disease.
